自体瘤溶酸荷载树突细胞疫苗接种免疫疗法后的瘤回归:说明案例
Ahmad I Kamaludin1, Naomi Sibtain2, Keyoumars Ashkan1
1Departments of Neurosurgery, King's College Hospital, London, United Kingdom.
Journal of neurosurgery. Case lessons
|July 8, 2024
概括
这项案例研究突出显示,在接受标准护理加上自身瘤溶解酸载荷树突细胞疫苗接种 (DCVax-L) 治疗的患者中,出现了不寻常的4级星系细胞瘤回归. 新型免疫疗法对这种难以治疗的大脑瘤显示出有希望的结果.
科学领域:
- 神经瘤学神经瘤学
- 免疫治疗是一种免疫疗法.
- 临床案例研究 临床案例研究
背景情况:
- 在过去二十年中,治疗4级质瘤的标准护理进展有限.
- 自主瘤溶解酸载荷树突细胞疫苗接种 (DCVax-L) 是一种新型免疫疗法,具有证明的生存益处.
研究的目的:
- 报告一个4级星细胞瘤回归的独特病例.
- 评估DCVax-L在结合质瘤治疗的标准护理中的潜在作用.
主要方法:
- 一名患有4级星系细胞瘤的患者接受了标准护理治疗和DCVax-L.
- 通过监视成像来监测瘤反应.
主要成果:
- 患者经历了显著的瘤回归,包括桃体残留瘤的完全回归.
- 剩余的额叶瘤也显示了大小的减少.
- 患者在治疗后保持良好的临床功能.
结论:
- 观察到的瘤回归仅在标准治疗中是不典型的,这表明DCVax-L.的潜在益处.
- 将DCVax-L与标准护理相结合,为管理4级星系细胞瘤提供了一个潜在的新策略.
- 这一案例强调了对DCVax-L对挑战性脑瘤的进一步调查的必要性.
相关概念视频
Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350


